Efficacy and Prognostic Factors of Androgen Deprivation Therapy Combined with Radiation Therapy for Prostate Cancer

Table 1

Between-group comparison of baseline data (n = 47).

Item	Combined group	Reference group	X^2/t	P
Mean age (mean ± SD, years)	63.37 ± 5.47	64.08 ± 5.39	0.634	0.528
BMI (mean ± SD, kg/m^2)	21.13 ± 4.37	21.17 ± 4.41	0.046	0.964
Prostate volume (mean ± SD, cm^3)	25.17 ± 3.28	25.13 ± 3.34	0.060	0.952
Disease duration (mean ± SD, month)	7.12 ± 2.14	7.15 ± 2.18	0.069	0.945
TNM pathological stage
II	25 (53.19%)	28 (59.57%)	0.389	0.533
III	17 (36.17%)	16 (34.04%)	0.047	0.829
IV	5 (10.64%)	3 (6.38%)	0.593	0.441
Accompanied metastasis
Bone metastasis	25 (53.19％)	22 (46.81％)	0.383	0.536
Lymph node metastasis	16 (34.04％)	12 (25.53％)	0.814	0.367
Viscera metastasis	6 (12.77％)	13 (27.66％)	3.232	0.072
Nationality (n(%))			0.712	0.399
Han	43 (91.49%)	45 (95.74%)
Non-Han	4 (8.51%)	2 (4.26%)
ECOG score
0 points	23 (48.94%)	25 (53.19%)	0.170	0.680
1 point	16 (34.04%)	15 (31.91%)	0.048	0.826
2 points	8 (17.02%)	7 (14.89%)	0.079	0.778
Degree of differentiation
Poor differentiation	14 (29.79%)	17 (36.17%)	0.433	0.510
Moderate differentiation	21 (44.68%)	20 (42.55%)	0.043	0.835
Well differentiation	12 (25.53%)	10 (21.28%)	0.237	0.626
Marital status (n(%))
Single	2 (4.26%)	3 (6.38%)	0.211	0.646
Married	41 (87.23%)	38 (80.85%)	0.714	0.398
Divorced	4 (8.51%)	6 (12.77%)	0.448	0.503
Place of residence (n(%))			0.170	0.680
Urban area	24 (51.06%)	22 (46.81%)
Rural area	23 (48.94%)	25 (53.19%)
Educational degree [n(%)]
Junior college and above	8 (17.02%)	10 (21.28%)	0.275	0.600
Senior high school	26 (55.32%)	23 (48.94%)	0.384	0.536
Junior high school and below	13 (27.66%)	14 (29.79%)	0.052	0.820